Abstract
The present disclosure belongs to the field of biotechnology and discloses a protein complex and production process thereof. The protein complex is obtained by stimulation of MSCs followed by lysis, and then isolation and purification. The protein complex has a strong ability to repair oxidative damage, which can reduce the size of cerebral infarction, improve neurological function, inhibit the level of neuroinflammation, and increase the number of surviving neurons.
Full Text
What is claimed is:
The present disclosure belongs to the field of biotechnology and discloses a protein complex and production process thereof. The protein complex is obtained by stimulation of MSCs followed by lysis, and then isolation and purification. The protein complex has a strong ability to repair oxidative damage, which can reduce the size of cerebral infarction, improve neurological function, inhibit the level of neuroinflammation, and increase the number of surviving neurons.
Timeline
Filed
04/14/2026Published
08/06/2026Granted
Not AvailableIPC Codes(12)
C12N 5/0775:Mesenchymal stem cells; Adipose-tissue derived stem cells
A61K 35/28:Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
A61K 38/00:Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K 31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K 31/00; ergoline-based peptides A61K 31/48; containing macromolecular compounds having statistically distributed amino acid units A61K 31/74; medicinal preparations containing antigens or antibodies A61K 39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K 47/00)